Author: Brittney Wheeler

Jennifer Phillips-Cremins, a pioneer in understanding 3D genome structure and its impact on the brain, will join WashU Medicine as BJC Investigator.

WashU Medicine researcher Benjamin Garcia will receive $18.5 million from the National Institutes of Health (NIH) to study how long-lived mammals stay healthy into old age.

The Rev. Callista Isabelle, the inaugural director for religious, spiritual and ethical life at WashU, received this year’s Gloria W. White Distinguished Service Award, which is given to a staff member who exceeds their daily work duties to make a positive impact on employees and the university at large.

Researchers at WashU Medicine led a study that offers a promising new way to reverse opioid overdoses without withdrawal symptoms.

Robi Mitra at WashU Medicine has received the Chancellor’s Award for Innovation and Entrepreneurship. In addition, in 2024 WashU jumped 11 places to No. 26 on the National Academy of Inventors list of the top 100 U.S. universities granted U.S. utility patents.

Barbara W. Trautner, MD, PhD, an internationally recognized physician-scientist, has been named the new co-director of the Division of Infectious Diseases in the Department of Medicine at WashU Medicine.

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

SPIE, the international society for optics and photonics, has awarded the prestigious SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics to Morgan Fogarty, a graduate student at WashU Medicine.

The Bouchet Graduate Honor Society, established in 2005 by Yale University and Howard University, recognizes outstanding scholarly achievement while promoting diversity and excellence in doctoral education and the professoriate. WashU recently inducted five doctoral candidates and five postdoctoral fellows.

A new study by WashU Medicine researchers suggests that lemborexant and sleep aids that work the same way could help treat or prevent damage caused by harmful buildup of the protein tau in multiple neurodegenerative diseases, including Alzheimer’s.